330 related articles for article (PubMed ID: 30785444)
1. Protection of hepatocyte mitochondrial function by blueberry juice and probiotics via SIRT1 regulation in non-alcoholic fatty liver disease.
Ren T; Zhu L; Shen Y; Mou Q; Lin T; Feng H
Food Funct; 2019 Mar; 10(3):1540-1551. PubMed ID: 30785444
[TBL] [Abstract][Full Text] [Related]
2. The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway.
Zhu J; Ren T; Zhou M; Cheng M
Drug Des Devel Ther; 2016; 10():1649-61. PubMed ID: 27274198
[TBL] [Abstract][Full Text] [Related]
3. Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1/STAT3/BAX signaling.
Zhu J; Zhou M; Zhao X; Mu M; Cheng M
Food Funct; 2018 Dec; 9(12):6298-6306. PubMed ID: 30411754
[TBL] [Abstract][Full Text] [Related]
4. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Ren T; Zhu J; Zhu L; Cheng M
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
[TBL] [Abstract][Full Text] [Related]
5. Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease.
Fan H; Shen Y; Ren Y; Mou Q; Lin T; Zhu L; Ren T
Nutr Metab (Lond); 2021 May; 18(1):50. PubMed ID: 33971886
[TBL] [Abstract][Full Text] [Related]
6. Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.
Li Z; Zhang H; Li Y; Chen H; Wang C; Wong VKW; Jiang Z; Zhang W
Phytomedicine; 2020 Apr; 69():153209. PubMed ID: 32240928
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
[No Abstract] [Full Text] [Related]
8. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
9. Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.
Ren T; Huang C; Cheng M
Oxid Med Cell Longev; 2014; 2014():469059. PubMed ID: 25544867
[TBL] [Abstract][Full Text] [Related]
10. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria.
García-Berumen CI; Ortiz-Avila O; Vargas-Vargas MA; Del Rosario-Tamayo BA; Guajardo-López C; Saavedra-Molina A; Rodríguez-Orozco AR; Cortés-Rojo C
Lipids Health Dis; 2019 Mar; 18(1):78. PubMed ID: 30927921
[TBL] [Abstract][Full Text] [Related]
11. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
13. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
[TBL] [Abstract][Full Text] [Related]
14. Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats.
Gaballah HH; El-Horany HE; Helal DS
J Cell Biochem; 2019 Aug; 120(8):12762-12774. PubMed ID: 30861601
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
Jiang Y; Chen D; Gong Q; Xu Q; Pan D; Lu F; Tang Q
Lipids Health Dis; 2021 Apr; 20(1):40. PubMed ID: 33902605
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
Stacchiotti A; Favero G; Lavazza A; Golic I; Aleksic M; Korac A; Rodella LF; Rezzani R
PLoS One; 2016; 11(1):e0148115. PubMed ID: 26824477
[TBL] [Abstract][Full Text] [Related]
17. [Effect of pure total flavonoids from citrus on hepatic SIRT1/PGC-1alpha pathway in mice with NASH].
Chen ZY; Li JS; Jiang JP; Yan MX; He BH
Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):100-5. PubMed ID: 24754177
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
[TBL] [Abstract][Full Text] [Related]
19. [The Effect of p-JAK1/p-STAT3 Signaling Way in Intervening NAFLD by Blueberry Probiotic Serum].
Zhu JJ; Cheng ML; Zhou MY; Zhao XK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):203-209. PubMed ID: 28612527
[TBL] [Abstract][Full Text] [Related]
20. A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats.
Abd Elwahab AH; Ramadan BK; Schaalan MF; Tolba AM
Cell Physiol Biochem; 2017; 43(2):644-659. PubMed ID: 28942443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
